NMPA Approval

Tirofiban Hydrochloride and Sodium Chloride Injection

Approval Number

国药准字H20193283

Company成都倍特药业股份有限公司

Registration Date

September 26, 2019

Drug Information

Generic Name

盐酸替罗非班氯化钠注射液

Dosage Form

注射剂

Strength

100ml:盐酸替罗非班(按C22H36N2O5S计)5mg与氯化钠0.9g

Drug Type

化学药品

Registration Date

September 26, 2019

Company Information

Applicant Company

Company Name成都倍特药业股份有限公司

Company Address

成都高新区和祥三街263号

Manufacturing Company

Company Name成都倍特药业股份有限公司

Company Address

成都市双流西南航空港经济开发区空港四路1166号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

盐酸替罗非班氯化钠注射液 - NMPA 批准文号 | MedPath